Mitchel S. Berger, MD

Harvard University, Cambridge, MA, A.B., 1975, Social Psychology
University of Miami, Miami, FL, M.D., 1979, Medicine
University of California, San Francisco, CA (UCSF), Dept. of Neurological Surgery, Brain Tumor Research Center (BTRC) Research Fellow 1983 - 1984 Neurosurgery
UCSF, BTRC, Neuro-Oncology Service, Clinical Fellow, 7/85 - 12/85, Neurosurgery
Hospital for Sick Children, Toronto, Ontario, Canada, Pediatric Neurosurgery Fellow, 1/86 - 6/86, Neurosurgery

• 1980 - 1982
  Residency, Dept. of Neurological Surgery, University of California, San Francisco, CA (UCSF)
• 1986 - 1992
  Asst. Professor, Dept. of Neurological Surgery, University of Washington, Seattle, WA
• 1990 - 1992
  Assoc. Professor, Dept. of Neurological Surgery, University of Washington, Seattle, WA
• 1995 - 1992
  American Cancer Society Prof. of Clinical Oncology, University of Washington, Seattle, WA
• 1996 - 1992
  Professor, Dept. of Neurological Surgery, University of Washington, Seattle, WA
• 1997 - present
  Professor and Chair, Dept. of Neurological Surgery, UCSF, San Francisco, CA
• 1997 - present
  Director, Brain Tumor Research Center, Dept. of Neurological Surgery, UCSF

• 1997-Present
  Joint Section on Tumors Advisory Council, American Association of Neurological Surgeons and Congress of Neurological Surgeons
• 1997-1999
  Vice-President, Congress of Neurological Surgeons; President, Society for Neuro-Oncology
• 2002-Present
  America’s Top Doctors, peer-nominated referral index from Castle Connolly
• 2006
  Tumor Section, 2006 Ronald L. Bittner Lecturer; 2006 Farber Award Winner
• 2007–Present
  Board of Directors of the American Association of Neurological Surgeons
• 2007–Present
  Member of the American Board of Neurological Surgeons
• 2010
  Vice-President, American Association of Neurological Surgeons
• 2011
  President Elect, American Association of Neurological Surgeons

• Sanai N., Mirzadeh Z., Berger M.S. (2008). Functional outcome after language mapping for glioma resection. New England Journal of Medicine, 358(1), 18-27. PMID: 18172171
• Smith J.S., Chang E.F., Lamborn K.R., Chang S.M., Prados M.D., Cha S., Tihan T., VandenBerg S., McDermott M.W., Berger M.S. (2008). The role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. Journal of Clinical Oncology, 26(8), 1338-1345. PMID: 18323558
• Chang E.F., Smith J.S., Chang S.M., Lamborn K.R., Prados M.D., Butowski N.B., Barbaro N.M., Parsa A.T., Berger M.S., McDermott M.W. (2008). Preoperative prognostic classification system for hemispheric low grade gliomas in adults. Journal of Neurosurgery, 109(5), 817-824. PMID: 18976070
• Chang S., Nelson S., VandenBerg S., Cha S., Prados M., Butowski N., McDermott M., Parsa A., Aghi M., Clarke J., Berger M.S. (2009). Integration of preoperative anatomic and metabolic/physiologic imaging of newly diagnosed glioma. Journal of Neuro-Oncology, 92(3), 401-415. PMCID: PMC2834319
• Wrensch M., Jenkins R.B., Chang J.S., Yeh R.F., Xiao Y., Ballman K.V., Berger M.S., Buckner J.C., Chang S., Decker P.A., Giannini C., Halder C., Kollmeyer T.M., Kosel M.L., LaChance D.H., McCoy L., O’Neill B., Patoka J., Picl A.R., Prados M., Quesenberry C., Rice T., Rynearson A., Smirnov I., Tihan T., Wiemels J., Yang P., Wiencke J.K. (2009). Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nature Genetics, 41(8), 905-908. PMCID: PMC2923561
• Chang E.F., Rieger J.W., Johnson K., Berger M.S., Barbaro N.M., Knight R.T. (2010). Categorical speech representation in human superior temporal gyrus. Nature Neuroscience, 13(11), 1428-1432. PMCID: PMC2967728
• Persson A.I., Petritsch C., Itsara M., Swartling F.J., Itsara M., Sim F.J., Auvergne R., Goldenberg D.D., VandenBerg S.R., Nguyen K.N., Yakovenkko S., Ayers-Ringler J., Nishiyama A., Stallcup W.B., Berger M.S., Bergers G., McKnight T.R., Goldman S.A., Weiss W.A. (2010). Non-stem cell origin for oligodendroglioma. Cancer Cell, 18(6), 669-682. PMCID: PMC3031116
• Chang E.F., Clark A., Smith J.S., Polley M.Y., Chang S.M., Barbaro N.M., Parsa A.T., McDermott M.W., Berger M.S. (2011). Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Journal of Neurosurgery, 114(3), 566-573. PMID:20635853
• Parsons D.W., Li M., Zhang X., et al. (2011). The genetic landscape of a childhood cancer. Science, 331(6016), 435-439. PMCID: PMC3110744
• Prasad G., Sottero T., Yang X., Mueller S., James C.D., Weiss W.A., Polley M-Y., Ozawa T., Berger M.S., Aftab D.T., Prados M.D., Haas Kogan D.A. (2011). Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide. Neuro-Oncology, 13(4), 384-392.
• Zheng S., Houseman E.A., Morrison Z., Wrensch M.R., Patoka J.S., Ramos C., Haas-Kogan D.A., McBride S., Marsit C.J., Christensen B.C., Nelson H.H., Stokoe D., Wiemels J.L., Chang S.M., Prados M.D., Tihan T., Vandenberg S.R., Kelsey K.T., Berger M.S., Wiencke J.K. (2011). DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Neuro-Oncology, 13(3), 280-289. PMCID: PMC3064601
• Martino J., Honma S.M., Findlay A.M., Owen J.P., Guggisberg A.G., Kirsch H.E., Berger M.S., Nagarajan S.S. (2011). Resting functional connectivity in patients with brain tumors in eloquent areas. Annals of Neurology, 69(3), 521-532.
• Sanai N., Polley M-Y., McDermott M.W., Parsa A.T., Berger M.S. (2011). An extent of resection threshold for newly diagnosed glioblastomas. Journal of Neurosurgery, 115(1), 3-8. PMID:21417701
• Englot D.J., Berger M.S., Barbaro N.M., Chang E.F. (2011). Predictors of seizure freedom after surgical resection of supratentorial low-grade gliomas. Journal of Neurosurgery, 115(2), 240-244. PMID:21529134
• Munoz E.G., Persson A.I., Sugiarto S., Waldhuber M., Lamagna C., Hanecker P., Ayers-Ringerler J., Phillips J., Stallcup Q., VandenBerg S., Berger M.S., Bergers G., Weiss W.A., Petritsch C. Loss of polarity and asymmetric division of oligodendrocyte progenitors accompanies initiation and progression of high-grade gliomagenesis. Cancer Cell. In Press. doi: 10.1016/j.ccr.2011.08.011